Comparisons of Metastatic Patterns, Survival Outcomes and Tumor Immune Microenvironment Between Young and Non-Young Breast Cancer Patients.

Front Cell Dev Biol · 2022 · PMC9329535 · PMID 35912097

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a study by Anders et al., young breast cancer (≤45 years) showed a trend toward inferior disease-free survival ( Anders et al., 2008 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.